Historical record - last NADAC publication: 5/17/2017
Product Information
LORAZEPAM 20 MG/10 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.6796 per ML under NDC 00641605010. Its NADAC has been published 153 times since Jan 22, 2014.
Strength
2 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641605010
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
5/17/2017
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018140On Market Since
7/25/1980
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 20 MG/10 ML VIAL has been published 153 times since Jan 22, 2014, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6796 per ML |
|---|---|
| All-time high | $0.7543 (Nov 12, 2014) |
| All-time low | $0.5700 (Nov 19, 2014) |
| Median price | $0.6796 |
| Average price | $0.6598 |
| Largest weekly change | -24.4% (Nov 19, 2014) |
| Weeks tracked | 153 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 20 MG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 20 MG/10 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.6796 per ML (NDC 00641605010), effective May 16, 2018.
How has the price of LORAZEPAM 20 MG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 20 MG/10 ML VIAL has declined 9.9%. It has been tracked across 153 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 20 MG/10 ML VIAL?
Since Jan 22, 2014, the NADAC for LORAZEPAM 20 MG/10 ML VIAL has ranged from a low of $0.5700 (Nov 19, 2014) to a high of $0.7543 (Nov 12, 2014), with a median of $0.6796 per ML.
Are there cheaper alternatives to LORAZEPAM 20 MG/10 ML VIAL?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LORAZEPAM 2 MG/ML ORAL CONCENT, is $0.6470 per ML — about 5% below LORAZEPAM 20 MG/10 ML VIAL.
Who manufactures LORAZEPAM 20 MG/10 ML VIAL?
LORAZEPAM 20 MG/10 ML VIAL (NDC 00641605010) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification